AMGEN Overview
AMGEN (AMGN) has a PEG ratio of 517.05, above the Healthcare sector average of 11.64.
Get informed when a big investor buys or sells
+ Follow517.05
The PEG ratio measures a stock's valuation relative to its earnings growth rate. A PEG ratio below 1.0 may indicate that the stock is undervalued relative to its growth potential.
The latest PEG ratio for AMGN is 517.05. That is above the Healthcare sector average of 11.64. Investors often review this figure alongside AMGEN's historical trend and sector peers before judging valuation or financial health.
Against Healthcare companies, AMGN currently prints 517.05 for PEG ratio, while the sector average sits near 11.64. That is roughly 4341.6% above the sector mean. Large gaps often invite a closer look at AMGEN's growth, margins, and balance sheet.
A PEG ratio of 517.05 for AMGEN is not 'good' or 'bad' on its own. Compare it with the peer average (11.64) and with AMGN's multi-year chart on this page. Persistently elevated multiples need growth or quality to justify them; depressed multiples need a catalyst or evidence the business is misunderstood.
After noting AMGN's PEG ratio (517.05), review year-over-year change, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.
This page's peer comparison chart is the fastest way to stack AMGEN's PEG ratio against similar Healthcare names. You can also browse sector and industry screens on Stockcircle for a broader set of Healthcare companies and their key multiples and fundamentals.
